Quest Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Whistleblower lawsuit leads to $11.4 mil. payment to settle charges that the firm billed Medicare for unnecessary apolipoprotein tests when doctors ordered other blood tests for cardiac risk evaluation, according to Washington D.C. law firm Phillips & Cohen, which represents the whistleblower. The "qui tam" suit alleging billing fraud from 1990 to 1997 was filed in 1997 by Kevin Spear, a salesman for Unilab, which Quest acquired in 2002...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.